These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1494357)

  • 1. Comparative studies on the postantifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans.
    Scalarone GM; Mikami Y; Kurita N; Yazawa K; Miyaji M
    Mycopathologia; 1992 Dec; 120(3):133-8. PubMed ID: 1494357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic postantifungal effect of flucytosine and fluconazole on Candida albicans.
    Mikami Y; Scalarone GM; Kurita N; Yazawa K; Uno J; Miyaji M
    J Med Vet Mycol; 1992; 30(3):197-206. PubMed ID: 1517958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparative evaluations of the postantifungal effect: synergistic interaction between flucytosine and fluconazole against Candida albicans.
    Scalarone GM; Mikami Y; Kurita N; Yazawa K; Uno J; Miyaji M
    Mycoses; 1991; 34(9-10):405-10. PubMed ID: 1820519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turbidometric characterization of the postantifungal effect: comparative studies with amphotericin B, 5-fluorocytosine and miconazole on Candida albicans.
    Scalarone GM; Mikami Y; Kurita N; Ichihara Y; Yazawa K; Miyaji M
    Mycoses; 1991; 34(7-8):297-302. PubMed ID: 1803230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of amphotericin B and flucytosine on hyphal growth of Candida albicans estimated at a single hypha level.
    Oh KB; Yang HC; Matsuoka H; Yamamoto A; Kurata H
    J Med Vet Mycol; 1995; 33(3):191-5. PubMed ID: 7666300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
    Ellepola AN; Samaranayake LP
    Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of human serum on the postantifungal effect of four antifungal agents on Candida albicans.
    Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1996; 42(4):273-9. PubMed ID: 8804795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The postantifungal effect of 5-fluorocytosine on Candida albicans.
    Scalarone GM; Mikami Y; Kurita N; Yazawa K; Miyaji M
    J Antimicrob Chemother; 1992 Feb; 29(2):129-36. PubMed ID: 1506327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ; DeLallo VC; Lewis RE; Ernst EJ; Klepser ME
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
    García MT; Llorente MT; Mínguez F; Prieto J
    Scand J Infect Dis; 2000; 32(6):669-73. PubMed ID: 11200379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN
    Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicans.
    Shadomy S; Shadomy HJ
    Diagn Microbiol Infect Dis; 1991; 14(1):21-2. PubMed ID: 2013207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
    Oz Y; Kiremitci A; Dag I; Metintas S; Kiraz N
    Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.
    Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
    J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postantifungal effect and effects of low concentrations of amphotericin B and fluconazole on previously treated Candida albicans.
    Mínguez F; García MT; Lima JE; Llorente MT; Prieto J
    Scand J Infect Dis; 1996; 28(5):503-6. PubMed ID: 8953682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
    J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the effect of combination of amphotericin B and flucytosine on Candida albicans by flow cytometry].
    Taguchi H; Tanaka R; Miyaji M; Nishimura K; Kanno H; Ishiyama H
    Kansenshogaku Zasshi; 1992 Apr; 66(4):516-21. PubMed ID: 1624846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of synergistic interactions between amphotericin B and flucytosine.
    Beggs WH
    J Antimicrob Chemother; 1986 Apr; 17(4):402-4. PubMed ID: 3519560
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.